SanDiskSNDK

Business Snapshot

• Sandisk Corporation (SNDK) is a US-listed common stock on NASDAQ, trading in USD. The provided payload does not include a sector, industry description, product breakdown, or company guidance.
• The stock is currently in pre-market trading at $1,737.99. The 200-day data series shows a move from $251.11 to $1,737.99, a gain of 592.12%.
• Price data is unusually volatile: the session high is $2,354.39 versus a session low of $183.00. This extreme range should be treated cautiously because the payload does not clarify whether it reflects a corporate-action adjustment, a data anomaly, or genuine trading volatility.

Financial Trends

• Revenue trajectory: Reported revenue increased every period: $2.308B on 2025-10-03, $3.025B on 2026-01-02, $5.950B on 2026-04-03, and $20.248B on 2026-07-03. The latest period rose $14.298B, or 240.3%, versus Q2, and $17.940B, or 777.4%, versus four periods ago. Growth is accelerating sharply, although the latest 10-K period is not directly comparable in duration to the quarterly 10-Q periods based solely on the provided labels.
• Gross margin: Gross margin expanded from 29.77% to 50.94%, then 78.35%, before declining to 71.47% in the latest period. The latest margin fell 6.88 percentage points versus Q2, but remains 41.70 points above four periods ago. The trajectory is still substantially improved, but the latest period shows a margin inflection downward.
• Operating margin: Operating margin rose from 7.63% to 35.21% and 69.09%, then decreased to 61.19%. That is a 7.90-point sequential decline, while remaining 53.56 points higher than four periods ago.
• Net margin: Net margin improved from 4.85% to 26.55%, then 60.76%, before easing to 56.46%. The latest margin is down 4.30 points versus Q2, but up 51.61 points from the earliest period.
• Free cash flow: FCF increased from $438M to $1.418B, $4.411B, and $11.494B. The latest figure rose $7.083B, or 160.6%, versus Q2, and $11.056B, or 2,524.2%, versus four periods ago. Cash generation is accelerating in absolute terms, though the latest period’s comparability caveat also applies.
• Cash flow composition: Cash from operations climbed from $488M to $1.507B, $4.545B, and $11.671B. Capital expenditures rose from $50M to $177M, but remained far below operating cash flow, supporting the reported FCF expansion.
• Balance-sheet trajectory: Total assets increased from $12.749B to $12.998B, $17.075B, and $22.507B. Equity rose from $9.381B to $15.736B, while retained earnings improved from negative $1.672B to $9.649B.
• Liquidity and debt: Cash increased from $1.442B to $4.762B, a $3.320B increase. Long-term debt declined from $1.331B to $583M, then to zero in the latest two periods. However, current liabilities jumped from $1.917B to $5.581B in the latest period, reducing the current ratio from 4.78 to 2.29, although liquidity remains above 2x on the reported figures.
• Shares: Shares outstanding were 147M, 148M, 148M, and 146M across the four periods, indicating a modest net reduction from the earliest to latest period.

Financial Health

• The latest reported period shows strong absolute financial health: $4.762B of cash, zero long-term debt, $7.199B of working capital, and $11.494B of FCF.
• Profitability has improved dramatically over the four periods, but the latest period marks a sequential cooling in gross, operating, and net margins. This is the primary financial trend to monitor: earnings and cash flow are accelerating, while profitability percentages have pulled back from Q2 peaks.
• Current liabilities rose substantially, causing the current ratio to fall from 4.78 to 2.29. That is not automatically a liquidity problem, but it represents a meaningful deterioration in short-term coverage compared with the prior period.
• The financial data does not include a full debt schedule, working-capital detail, quarterly guidance, valuation multiples, or segment results. The apparent strength of the latest period should therefore be evaluated alongside the unusually large period-to-period revenue and earnings changes.

Insider Activity

• Insider sentiment is classified as Neutral (-10), but the underlying transactions are heavily skewed toward selling: $168.729M of sales across 50 transactions, with no reported purchases across one transaction.
• Selling was broad-based across multiple named insiders, including David Goeckeler, Bernard Shek, Alper Ilkbahar, Luis Felipe Visoso, and Michael Pokorny.
• The largest reported transaction was David Goeckeler’s sale of 49,782 shares for approximately $73.716M at $1,480.77 on August 25, 2026.
• Additional large sales included approximately $16.390M by David Goeckeler, $9.078M by Luis Felipe Visoso, $4.079M by Bernard Shek, and $5.044M by Alper Ilkbahar.
• These transactions occurred at prices from approximately $1,480.77 to $1,767.33, below or near the current pre-market price of $1,737.99. The payload does not identify whether the sales were scheduled, tax-related, equity-compensation-related, or discretionary, so they are a risk signal rather than definitive evidence of deteriorating fundamentals.

Multi-Timeframe Technical Context

• Ultra-short horizon — minutes: The stock is in pre-market trading, so liquidity and price discovery may be less reliable. The reported session range of $183.00 to $2,354.39 is exceptionally wide relative to the current price and warrants caution around market orders, spreads, and apparent breakout signals.
• Short horizon — hours to days: Price is above the 12-day EMA of $1,587.30, 26-day EMA of $1,544.34, 50-day EMA of $1,531.39, 20-day SMA of $1,554.80, and 50-day SMA of $1,543.20. This confirms a strong upward trend across the supplied daily indicators.
• Daily MACD is positive: 42.96 versus a signal line of 17.88, indicating bullish momentum. However, RSI is mixed by lookback: RSI-14 is 60.05, while RSI-21 is 70.32. Momentum remains positive, but the longer RSI is at a level commonly associated with an extended move.
• Price is near the upper Bollinger Band: $1,737.99 versus an upper band of $1,800.31, with a middle band of $1,554.80. This supports trend strength but also leaves room for mean reversion if momentum fades.
• Current volume is 11.20M, below the 20-day average of 13.30M, or approximately 15.8% lower. A continued advance on below-average volume would be less convincing than a move accompanied by expanding participation.
• Longer horizon — weeks to months: The price remains well above the 200-day SMA of $1,011.43, supporting a powerful long-term uptrend. Conversely, the 200-bar gain of 592.12%, elevated volatility, insider selling, and the latest margin decline increase the risk of sharp pullbacks and trend resets.

Bull / Bear Cases

• Short-term bull case:

  • Price is above all supplied short- and intermediate-term moving averages.
  • MACD remains bullish, and price is close to the upper Bollinger Band rather than below trend support.
  • A sustained move above approximately $1,800, the upper Bollinger Band, could signal continuation if supported by increasing volume.
  • Strong reported FCF and cash accumulation may help support investor confidence if the financial trend remains intact.

• Short-term bear case:

  • RSI-21 at 70.32 indicates an extended condition, while the price is near the upper Bollinger Band.
  • Volume is below its 20-day average, weakening confirmation of the current advance.
  • A break below the $1,587-$1,555 area would threaten the short-term trend, as that zone contains the 12-day EMA, 20-day SMA, and 26-day/50-day averages.
  • The extreme session range creates substantial gap and slippage risk, particularly during pre-market trading.

• Long-term bull case:

  • Revenue, operating income, net income, and FCF all increased in each supplied period.
  • Latest FCF of $11.494B is more than 26 times the earliest reported period’s $438M.
  • Cash increased materially, long-term debt reached zero, retained earnings turned strongly positive, and shares outstanding modestly declined.
  • The stock’s position above the 200-day SMA reflects strong longer-term price momentum.

• Long-term bear case:

  • Gross, operating, and net margins all declined sequentially in the latest period, suggesting potential normalization after a very strong expansion.
  • Current liabilities increased by $3.664B from Q2 to the latest period, and the current ratio dropped from 4.78 to 2.29.
  • Insider activity shows significant, broad-based selling with no reported buying in the stated window.
  • The stock has already risen 592.12% across the supplied 200-bar series, making valuation and execution expectations potentially demanding; however, no market capitalization, valuation multiple, analyst target, or guidance data is provided to quantify that risk.

Key Levels & Triggers

• $1,800: Approximate upper Bollinger Band at $1,800.31. A decisive break and hold above it, ideally with volume above the 13.30M 20-day average, would support continuation.
• $1,587: 12-day EMA and near-term trend reference. Loss of this level would indicate weakening short-term momentum.
• $1,555-$1,544: Cluster of the 20-day SMA ($1,554.80), 26-day EMA ($1,544.34), and 50-day SMA ($1,543.20). A sustained break below this zone would materially weaken the daily trend.
• $1,531: 50-day EMA. This is an additional medium-term support reference.
• $1,309: Lower Bollinger Band. A move toward this level would represent a deeper mean-reversion scenario rather than a routine pullback.
• $1,011: 200-day SMA and major long-term trend reference.
• Fundamental triggers: Watch whether revenue and FCF continue rising, whether gross margin stabilizes after the decline from 78.35% to 71.47%, and whether current liabilities normalize or continue increasing.
• Insider and liquidity trigger: Continued large insider sales without offsetting purchases would reinforce supply and sentiment risks. Because the stock is in pre-market trading and the reported range is unusually wide, confirmation should rely on regular-session price action, liquidity, and volume rather than pre-market prints alone.